Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Head and Neck Cancer Study Project in the Geriatric Population
NCT06998069Phase 3Recruiting
- Sponsor
- Brown University
- Start
- Aug 2025
- Primary completion
- Dec 2026
- Modality
- Immune Checkpoint Inhibitors, Antibody Conjugates, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of pembrolizumab, KL-140, carboplatin, Paclitaxel Micelles for Injection in squamous cell carcinoma of the head and neck (HNSCC), sponsored by Brown University. Started Aug 2025; status: recruiting.
02
Drugs
03
Conditions
squamous cell carcinoma of the head and neck (HNSCC)
Beyond the preview
Go deeper on NCT06998069.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06998069.